Combination of oxymetazoline and ipratropium nasal topical Application for the treatment of Cough

摘要

The present Invention is effective for the treatment and Relief of Cough caused by postnasal Drip, using the combination of oxymetazoline and ipratropium.The active ingredients contained in the mixture of the present Invention have been used and marketed separately with the different uses of the present Invention.To remove the secretion and oxymetazoline nasal congestion (obstruction)And the effects of ipratropium bromide sold to dilate the bronchi in patients with Asthma and chronic obstructive pulmonary diseaseAlthough Experimentally has also been used to decrease nasal Discharge. Both Active agents, separately or together did not have up to now used as antitussives intranasally.The cough caused by postnasal Drip, it is the most common cause of Cough in humans of any ageThe present Invention is effective for the treatment and alleviation of the Symptom.